DWP
GSK icon

Destiny Wealth Partners’s GSK GSK Stock Holding History

Destiny Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-537
Closed -$29.6K – 532
2026
Q1 		$29.6K Buy
+537
New +$29.1K ﹤0.01% 555
2023
Q1 		– Sell
-274
Closed -$9.63K – 359
2022
Q4 		$9.63K Buy
+274
New +$9.13K ﹤0.01% 483
2021
Q2 		– Sell
-8
Closed – – 316
2021
Q1 		$0 Hold
8
– – ﹤0.01% 555
2020
Q4 		$0 Buy
+8
New +$367 ﹤0.01% 506

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Destiny Wealth Partners's GSK Position: Q2 2026 in Review

Destiny Wealth Partners sold out of GSK (GSK) in Q2 2026, closing a stake of 537 shares — an estimated $29.6K sold.

Destiny Wealth Partners first reported a position in GSK in Q4 2020 and held it in 4 quarters. The position peaked at $29.6K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Destiny Wealth Partners reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Destiny Wealth Partners sold 537 GSK shares in Q2 2026, an estimated $29.6K.
  • Destiny Wealth Partners first reported a position in GSK in Q4 2020 and held it in 4 quarters.
  • Destiny Wealth Partners's GSK position peaked at $29.6K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.